Skip to main content
Erschienen in: Archives of Dermatological Research 7/2016

01.07.2016 | Original Paper

Muscarinic cholinergic receptors (MR3) in saliva of patients with oral lichen planus

verfasst von: Farzaneh Agha-Hosseini, Iraj Mirzaii-Dizgah, Neda Mohammadpour

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Oral lichen planus (OLP) is a relatively common, chronic, and inflammatory mucocutaneous disease. Xerostomia is also a common complaint of most OLP patients. Considering the significant role of M3 muscarinic receptors (M3R) in secretion of saliva, this study sought to compare the level of this receptor in saliva between OLP patients and healthy controls. Forty OLP patients and 40 healthy controls filled out two questionnaires regarding xerostomia to assess its degree of severity. Unstimulated and stimulated salivary samples were obtained of both groups and the stimulated and unstimulated salivary flow rates were calculated. Salivary level of M3 muscarinic receptors was measured using the ELISA kit. Data were analyzed and compared using unpaired student’s t test. P < 0.05 was considered significant. Stimulated and unstimulated salivary flow rates and M3 muscarinic receptors levels were significantly lower but degree of xerostomia was significantly higher in OLP patients compared to healthy controls. Salivary M3 muscarinic receptor seems to be low in the patients with OLP and these patients suffer from xerostomia and reduced salivary flow rate.
Literatur
1.
Zurück zum Zitat Agarwal P (2003) Immunopathogenesis of Sjögren’s syndrome. J Indian Rheumatol Assoc 11(3):71–75 Agarwal P (2003) Immunopathogenesis of Sjögren’s syndrome. J Indian Rheumatol Assoc 11(3):71–75
2.
Zurück zum Zitat Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM (2006) Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Med Oral Patol Oral Cir Bucal 11(2):E126–E129PubMed Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM (2006) Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Med Oral Patol Oral Cir Bucal 11(2):E126–E129PubMed
3.
Zurück zum Zitat Agha-Hosseini F, Mirzaii-Dizgah I, Abdollahi M, Akbari-Gillani N (2011) Efficacy of IMOD in the treatment of oral lichen planus. Open J Stomatol 1:13CrossRef Agha-Hosseini F, Mirzaii-Dizgah I, Abdollahi M, Akbari-Gillani N (2011) Efficacy of IMOD in the treatment of oral lichen planus. Open J Stomatol 1:13CrossRef
6.
Zurück zum Zitat Agha-Hosseini F, Mirzaii-Dizgah I, Moosavi M-S (2011) Relationship of lumbar spine bone mineral density and oral dryness feeling in menopause. Menopause 18(6):625–628CrossRefPubMed Agha-Hosseini F, Mirzaii-Dizgah I, Moosavi M-S (2011) Relationship of lumbar spine bone mineral density and oral dryness feeling in menopause. Menopause 18(6):625–628CrossRefPubMed
7.
8.
Zurück zum Zitat Brand HS, Veerman E (2013) Saliva and wound healing. Chin J Dent Res 16:7–12PubMed Brand HS, Veerman E (2013) Saliva and wound healing. Chin J Dent Res 16:7–12PubMed
9.
Zurück zum Zitat Budimir V, Richter I, Andabak-Rogulj A, Vučićević-Boras V, Budimir J, Brailo V (2014) Oral lichen planus—retrospective study of 563 Croatian patients. Med Oral Patol Oral Cir Bucal 19(3):e255–e260CrossRefPubMedPubMedCentral Budimir V, Richter I, Andabak-Rogulj A, Vučićević-Boras V, Budimir J, Brailo V (2014) Oral lichen planus—retrospective study of 563 Croatian patients. Med Oral Patol Oral Cir Bucal 19(3):e255–e260CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Colquhoun AN, Ferguson MM (2004) An association between oral lichen planus and a persistently dry mouth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98(1):60–68CrossRefPubMed Colquhoun AN, Ferguson MM (2004) An association between oral lichen planus and a persistently dry mouth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98(1):60–68CrossRefPubMed
11.
Zurück zum Zitat Dawes C (2004) How much saliva is enough for avoidance of xerostomia? Caries Res 38:236–240CrossRefPubMed Dawes C (2004) How much saliva is enough for avoidance of xerostomia? Caries Res 38:236–240CrossRefPubMed
12.
Zurück zum Zitat Gorouhi F, Davari P, Fazel N (2014) Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Sci World J 2014:742826. doi:10.1155/2014/742826 CrossRef Gorouhi F, Davari P, Fazel N (2014) Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Sci World J 2014:742826. doi:10.​1155/​2014/​742826 CrossRef
13.
Zurück zum Zitat Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T (2010) Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialoadenitis. J Autoimmun 35(4):383–389. doi:10.1016/j.jaut.2010.08.004 CrossRefPubMed Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T (2010) Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialoadenitis. J Autoimmun 35(4):383–389. doi:10.​1016/​j.​jaut.​2010.​08.​004 CrossRefPubMed
14.
Zurück zum Zitat Ito Y, Oyunzul L, Yoshida A, Fujino T, Noguchi Y, Yuyama H, Ohtake A, Suzuki M, Sasamata M, Matsui M, Yamada S (2009) Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice. Eur J Pharmacol 615(1–3):201–206. doi:10.1016/j.ejphar.2009.04.068 CrossRef Ito Y, Oyunzul L, Yoshida A, Fujino T, Noguchi Y, Yuyama H, Ohtake A, Suzuki M, Sasamata M, Matsui M, Yamada S (2009) Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice. Eur J Pharmacol 615(1–3):201–206. doi:10.​1016/​j.​ejphar.​2009.​04.​068 CrossRef
15.
18.
Zurück zum Zitat Kruszka P, O’Brian RJ (2009) Diagnosis and management of Sjögren syndrome. Am Fam Physician 79(6):465–470PubMed Kruszka P, O’Brian RJ (2009) Diagnosis and management of Sjögren syndrome. Am Fam Physician 79(6):465–470PubMed
19.
Zurück zum Zitat López-Jornet P, Parra-Perez F, Pons-Fuster A (2014) Association of autoimmune diseases with oral lichen planus: a cross-sectional, clinical study. J Eur Acad Dermatol Venereol 28(7):895–899. doi:10.1111/jdv.12202 CrossRefPubMed López-Jornet P, Parra-Perez F, Pons-Fuster A (2014) Association of autoimmune diseases with oral lichen planus: a cross-sectional, clinical study. J Eur Acad Dermatol Venereol 28(7):895–899. doi:10.​1111/​jdv.​12202 CrossRefPubMed
20.
Zurück zum Zitat Lundström IM, Anneroth KG, Bergstedt HF (1982) Salivary gland function and changes in patients with oral lichen planus. Scand J Dent Res 90(6):443–458PubMed Lundström IM, Anneroth KG, Bergstedt HF (1982) Salivary gland function and changes in patients with oral lichen planus. Scand J Dent Res 90(6):443–458PubMed
21.
Zurück zum Zitat Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA (2004) Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 294(2):534–549CrossRefPubMed Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA (2004) Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 294(2):534–549CrossRefPubMed
22.
Zurück zum Zitat Reina S, Sterin-Borda L, Passafaro D, Borda E (2011) Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren’s syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands. Arch Oral Biol 56(5):413–420. doi:10.1016/j.archoralbio.2010.08.017 CrossRefPubMed Reina S, Sterin-Borda L, Passafaro D, Borda E (2011) Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren’s syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands. Arch Oral Biol 56(5):413–420. doi:10.​1016/​j.​archoralbio.​2010.​08.​017 CrossRefPubMed
24.
Zurück zum Zitat Ryberg AT, Warfvinge G, Axelsson L, Soukup O, Götrick B, Tobin G (2008) Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man. Arch Oral Biol 53(1):66–74CrossRefPubMed Ryberg AT, Warfvinge G, Axelsson L, Soukup O, Götrick B, Tobin G (2008) Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man. Arch Oral Biol 53(1):66–74CrossRefPubMed
25.
Zurück zum Zitat Shida T, Tokunaga A, Kondo E, Ueda Y, Ohno K, Saika T, Kiyama H, Tohyama M (1993) Expression of muscarinic and nicotinic receptor mRNA in the salivary gland of rats: a study by in situ hybridization histochemistry. Brain Res Mol Brain Res 17(3–4):335–339CrossRefPubMed Shida T, Tokunaga A, Kondo E, Ueda Y, Ohno K, Saika T, Kiyama H, Tohyama M (1993) Expression of muscarinic and nicotinic receptor mRNA in the salivary gland of rats: a study by in situ hybridization histochemistry. Brain Res Mol Brain Res 17(3–4):335–339CrossRefPubMed
26.
Zurück zum Zitat Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365CrossRefPubMed Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365CrossRefPubMed
27.
Zurück zum Zitat Tobin G, Giglio D, Götrick B (2002) Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton Neurosci 100(1–2):1–9CrossRefPubMed Tobin G, Giglio D, Götrick B (2002) Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton Neurosci 100(1–2):1–9CrossRefPubMed
29.
Zurück zum Zitat van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32(9):507–512CrossRefPubMed van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32(9):507–512CrossRefPubMed
31.
Zurück zum Zitat Yamada S, Maruyama S, Takagi Y, Uchida S, Oki T (2006) In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci 80(2):127–132CrossRefPubMed Yamada S, Maruyama S, Takagi Y, Uchida S, Oki T (2006) In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci 80(2):127–132CrossRefPubMed
Metadaten
Titel
Muscarinic cholinergic receptors (MR3) in saliva of patients with oral lichen planus
verfasst von
Farzaneh Agha-Hosseini
Iraj Mirzaii-Dizgah
Neda Mohammadpour
Publikationsdatum
01.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 7/2016
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1670-7

Weitere Artikel der Ausgabe 7/2016

Archives of Dermatological Research 7/2016 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.